AmoyDx and PREMIA Announce the Commercial Launch of the AmoyDx® Pan Lung Cancer PCR Panel in Japan

NEXT STORY
Akoya Biosciences Announces Commercial Launch of PhenoCycler-Fusion, the Fastest Single-Cell Spatial Biology System
PREV STORY
BridgeBio Announces Clinical Collaboration with Amgen to Study BBP-398, a Potentially Best-in-class SHP2 Inhibitor, in Combination with LUMAKRAS® (sotorasib) in Advanced Solid Tumors with the KRAS G12C Mutation
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Nuance Expands Vision and Capabilities for Next Generation AI Powered Virtual Assistants for Healthcare

Company showcases unified vision for ambient clinical documentation and announces general availability of virtual ...

author_avatar
NASDAQ Market News

Genocea Provides First Quarter 2021 Corporate Update

author_avatar
NASDAQ Market News

Rubius Therapeutics Presents Initial Clinical Results from the Ongoing Phase 1/2 Clinical Trial of RTX-240 in Advanced Solid Tumors at the American Association of Cancer Research Virtual Annual Meeting

author_avatar
NASDAQ Market News